Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression.

Braicu C, Buiga R, Cojocneanu R, Buse M, Raduly L, Pop LA, Chira S, Budisan L, Jurj A, Ciocan C, Magdo L, Irimie A, Dobrota F, Petrut B, Berindan-Neagoe I.

J Exp Clin Cancer Res. 2019 Oct 29;38(1):433. doi: 10.1186/s13046-019-1406-6.

2.

Next-generation sequencing-based characterization of the invasion by anatomical contiguity in a primary osseous diffuse large B-cell lymphoma. Correlation between the genetic profile of the malignancy and the clinical outcome of the patient.

Zaharie F, Pop LA, Petrushev B, Jurj A, Muresan MS, Eniu D, Fetica B, Petkov B, Pasca S, Piciu D, Rus I, Deak D, Dima D, Desmirean MS, Tomuleasa C, Berindan-Neagoe I.

Histol Histopathol. 2019 Jun;34(6):663-670. doi: 10.14670/HH-18-067. Epub 2018 Nov 23.

PMID:
30467824
3.

Aberrant miRNAs expressed in HER-2 negative breast cancers patient.

Braicu C, Raduly L, Morar-Bolba G, Cojocneanu R, Jurj A, Pop LA, Pileczki V, Ciocan C, Moldovan A, Irimie A, Eniu A, Achimas-Cadariu P, Paradiso A, Berindan-Neagoe I.

J Exp Clin Cancer Res. 2018 Oct 20;37(1):257. doi: 10.1186/s13046-018-0920-2.

4.

The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge.

Temian DC, Pop LA, Irimie AI, Berindan-Neagoe I.

J Breast Cancer. 2018 Sep;21(3):233-243. doi: 10.4048/jbc.2018.21.e41. Epub 2018 Sep 20. Review.

5.

The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression.

Gulei D, Magdo L, Jurj A, Raduly L, Cojocneanu-Petric R, Moldovan A, Moldovan C, Florea A, Pasca S, Pop LA, Moisoiu V, Budisan L, Pop-Bica C, Ciocan C, Buiga R, Muresan MS, Stiufiuc R, Ionescu C, Berindan-Neagoe I.

Cell Death Dis. 2018 Jan 19;9(2):66. doi: 10.1038/s41419-017-0102-8.

6.

Genetic alterations in sporadic triple negative breast cancer.

Pop LA, Cojocneanu-Petric RM, Pileczki V, Morar-Bolba G, Irimie A, Lazar V, Lombardo C, Paradiso A, Berindan-Neagoe I.

Breast. 2018 Apr;38:30-38. doi: 10.1016/j.breast.2017.11.006. Epub 2017 Dec 5.

PMID:
29202330
7.

The new era of nanotechnology, an alternative to change cancer treatment.

Jurj A, Braicu C, Pop LA, Tomuleasa C, Gherman CD, Berindan-Neagoe I.

Drug Des Devel Ther. 2017 Sep 27;11:2871-2890. doi: 10.2147/DDDT.S142337. eCollection 2017. Review.

8.

miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples.

Braicu OL, Budisan L, Buiga R, Jurj A, Achimas-Cadariu P, Pop LA, Braicu C, Irimie A, Berindan-Neagoe I.

Onco Targets Ther. 2017 Aug 28;10:4225-4238. doi: 10.2147/OTT.S137107. eCollection 2017.

9.

HLA Genotyping using Next Generation Sequencing.

Lucan C, Pop LA, Florian A, Pileczki V, Petrushev B, Dima D, Frinc I, Berindan-Neagoe I, Irimie A, Berce C, Florian IS, Bojan A, Tomuleasa C.

Rom J Intern Med. 2016 Apr-Jun;54(2):98-104. doi: 10.1515/rjim-2016-0019. Review.

PMID:
27352438
10.

Normalization of gene expression measurement of tissue samples obtained by transurethral resection of bladder tumors.

Pop LA, Pileczki V, Cojocneanu-Petric RM, Petrut B, Braicu C, Jurj AM, Buiga R, Achimas-Cadariu P, Berindan-Neagoe I.

Onco Targets Ther. 2016 Jun 2;9:3369-80. doi: 10.2147/OTT.S97519. eCollection 2016.

11.

Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon Cancer.

Zaharie F, Muresan MS, Petrushev B, Berce C, Gafencu GA, Selicean S, Jurj A, Cojocneanu-Petric R, Lisencu CI, Pop LA, Pileczki V, Eniu D, Muresan MA, Zaharie R, Berindan-Neagoe I, Tomuleasa C, Irimie A.

J Gastrointestin Liver Dis. 2015 Dec;24(4):435-43. doi: 10.15403/jgld.2014.1121.244.375.

12.

Next generation sequencing applications for breast cancer research.

Petric RC, Pop LA, Jurj A, Raduly L, Dumitrascu D, Dragos N, Neagoe IB.

Clujul Med. 2015;88(3):278-87. doi: 10.15386/cjmed-486. Epub 2015 Jul 1. Review.

13.

Breast tumor bank: an important resource for developing translational cancer research in Romania.

Braicu C, Berindan-Neagoe I, Pileczki V, Cojocneanu-Petric R, Pop LA, Puscas E, Irimie A, Buiga R.

Cancer Biomark. 2014;14(2-3):119-27. doi: 10.3233/CBM-130309.

PMID:
24878812
14.

Quality control of ion torrent sequencing library.

Pop LA, Puscas E, Pileczki V, Cojocneanu-Petric R, Braicu C, Achimas-Cadariu P, Berindan-Neagoe I.

Cancer Biomark. 2014;14(2-3):93-101. doi: 10.3233/CBM-130358.

PMID:
24878810
15.

Acute toxicity profile and compliance to accelerated radiotherapy plus carbogen and nicotinamide for clinical stage T2-4 laryngeal cancer: results of a phase III randomized trial.

Janssens GO, Terhaard CH, Doornaert PA, Bijl HP, van den Ende P, Chin A, Pop LA, Kaanders JH.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):532-8. doi: 10.1016/j.ijrobp.2010.11.045. Epub 2011 Feb 6.

PMID:
21300447
16.

Long-term outcome and morbidity after treatment with accelerated radiotherapy and weekly cisplatin for locally advanced head-and-neck cancer: results of a multidisciplinary late morbidity clinic.

Rütten H, Pop LA, Janssens GO, Takes RP, Knuijt S, Rooijakkers AF, van den Berg M, Merkx MA, van Herpen CM, Kaanders JH.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):923-9. doi: 10.1016/j.ijrobp.2010.07.013. Epub 2010 Nov 20.

PMID:
21095074
17.

External beam radiotherapy with endocavitary boost for nasopharyngeal cancer: treatment results and late toxicity after extended follow-up.

Schinagl DA, Marres HA, Kappelle AC, Merkx MA, Pop LA, Verstappen SM, Kaanders JH.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):689-95. doi: 10.1016/j.ijrobp.2009.08.072. Epub 2010 Mar 16.

PMID:
20231060
18.

Bath and shower effect in spinal cord: the effect of time interval.

Philippens ME, Pop LA, Visser AG, Peeters WJ, van der Kogel AJ.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):514-22. doi: 10.1016/j.ijrobp.2008.09.028. Epub 2008 Nov 27.

PMID:
19046823
19.

Dose-volume effects in rat thoracolumbar spinal cord: the effects of nonuniform dose distribution.

Philippens ME, Pop LA, Visser AG, van der Kogel AJ.

Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):204-13.

PMID:
17707274
20.

Effects of hyperoxygenation on FDG-uptake in head-and-neck cancer.

de Geus-Oei LF, Kaanders JH, Pop LA, Corstens FH, Oyen WJ.

Radiother Oncol. 2006 Jul;80(1):51-6. Epub 2006 Jul 3.

PMID:
16820237
21.

Treatment results of patients with a squamous cell carcinoma of the buccal mucosa.

Coppen C, de Wilde PC, Pop LA, van den Hoogen FJ, Merkx MA.

Oral Oncol. 2006 Sep;42(8):795-9. Epub 2006 Mar 10.

PMID:
16529979
22.

Oxygen-modifying treatment with ARCON reduces the prognostic significance of hemoglobin in squamous cell carcinoma of the head and neck.

Hoogsteen IJ, Pop LA, Marres HA, Merkx MA, van den Hoogen FJ, van der Kogel AJ, Kaanders JH.

Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):83-9. Epub 2005 Oct 5.

PMID:
16213107
23.

Dose-volume effects in rat thoracolumbar spinal cord: an evaluation of NTCP models.

Philippens ME, Pop LA, Visser AG, Schellekens SA, van der Kogel AJ.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):578-90.

PMID:
15380595
24.

Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.

Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, van den Hoogen FJ, de Wilde PC, Bussink J, Raleigh JA, van der Kogel AJ.

Cancer Res. 2002 Dec 1;62(23):7066-74.

25.

ARCON: experience in 215 patients with advanced head-and-neck cancer.

Kaanders JH, Pop LA, Marres HA, Bruaset I, van den Hoogen FJ, Merkx MA, van der Kogel AJ.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):769-78.

PMID:
11849800
26.

Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy.

Pop LA, Millar WT, Visser AG, van der Kogel AJ.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):215-26.

PMID:
11516872
27.

Post-radiotherapy contrast enhancement changes in fast dynamic MRI of cervical carcinoma.

Boss EA, Massuger LF, Pop LA, Verhoef LC, Huisman HJ, Boonstra H, Barentsz JO.

J Magn Reson Imaging. 2001 Apr;13(4):600-6.

PMID:
11276105
28.

HDR brachytherapy applied to cervical carcinoma with moderate lateral expansion: modified principles of treatment.

Kuipers T, Hoekstra CJ, van 't Riet A, Mak AC, Vonk EJ, Elders LH, Koster K, Pop LA.

Radiother Oncol. 2001 Jan;58(1):25-30.

PMID:
11165678
29.

Radiation tolerance of rat spinal cord to pulsed dose rate (PDR-) brachytherapy: the impact of differences in temporal dose distribution.

Pop LA, Millar WT, van der Plas M, van der Kogel AJ.

Radiother Oncol. 2000 Jun;55(3):301-15.

PMID:
10869745
30.

Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.

Kaanders JH, Pop LA, Marres HA, Liefers J, van den Hoogen FJ, van Daal WA, van der Kogel AJ.

Radiother Oncol. 1998 Aug;48(2):115-22.

PMID:
9783882
31.

Tolerance of rat spinal cord to continuous interstitial irradiation.

Pop LA, van der Plas M, Ruifrok AC, Schalkwijk LJ, Hanssen AE, van der Kogel AJ.

Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):681-9.

PMID:
9486620
32.

High dose rate (HDR) and low dose rate (LDR) interstitial irradiation (IRT) of the rat spinal cord.

Pop LA, van der Plas M, Skwarchuk MW, Hanssen AE, van der Kogel AJ.

Radiother Oncol. 1997 Jan;42(1):59-67.

PMID:
9132828
33.
34.

Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity.

Kaanders JH, Pop LA, Marres HA, van der Maazen RW, van der Kogel AJ, van Daal WA.

Radiother Oncol. 1995 Dec;37(3):190-8.

PMID:
8746587
36.

Evaluation of treatment results of squamous cell carcinoma of the buccal mucosa.

Pop LA, Eijkenboom WM, de Boer MF, de Jong PC, Knegt P, Levendag PC, Meeuwis CA, Reichgelt BA, van Putten WL.

Int J Radiat Oncol Biol Phys. 1989 Feb;16(2):483-7.

PMID:
2921152

Supplemental Content

Support Center